Skip to main content
Top

08-05-2024 | Intoxication | Nephrology – Letter to the Editor

Tubulointerstitial injury and renal outcome after minimum lethal dose of diquat intoxication

Authors: ZhiPeng Zhao, ShuLing Yue, Jie Feng, HongRui Cui, LiJun Sun, Guang Yang, LiHong Zhang, Tao Wang

Published in: International Urology and Nephrology

Login to get access

Excerpt

Editor, …
Literature
5.
go back to reference Magalhães N, Carvalho F, Dinis-Oliveira RJ (2018) Human and experimental toxicology of diquat poisoning: toxicokinetics, mechanisms of toxicity, clinical features, and treatment. Hum Exp Toxicol 37(11):1131–1135CrossRefPubMed Magalhães N, Carvalho F, Dinis-Oliveira RJ (2018) Human and experimental toxicology of diquat poisoning: toxicokinetics, mechanisms of toxicity, clinical features, and treatment. Hum Exp Toxicol 37(11):1131–1135CrossRefPubMed
Metadata
Title
Tubulointerstitial injury and renal outcome after minimum lethal dose of diquat intoxication
Authors
ZhiPeng Zhao
ShuLing Yue
Jie Feng
HongRui Cui
LiJun Sun
Guang Yang
LiHong Zhang
Tao Wang
Publication date
08-05-2024
Publisher
Springer Netherlands
Published in
International Urology and Nephrology
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-024-04076-8
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.